Hemos encontrado 361 documentos que coinciden con su criterio de búsqueda

  1. Ir. Tanja Vervust

    Ir. Tanja Vervust Global Director, Rousselot Biomedical Tanja holds an MSc in Bioscience Engineering from Ghent University and has over 25 years of experience with Rousselot. In January 2018, Tanja was appointed Global Director Rousselot Biomedical. Which aspect of your work inspires you the most? A

  2. Noticias - Rousselot Biomedical

    Resumen de noticias Biomedical , rousselot Rousselot, la marca de salud de Darling Ingredients, anuncia el acceso Online/ internet a las gelatinas X-Pure de grado técnico y de investigación a través de BIO INX Rousselot, la marca de salud de Darling Ingredients, líder mundial en soluciones a base de

  3. Blogs y testimonios - Rousselot Biomedical

    Visión general del blog Biomedical Biomaterials for safe & effective embolization As medical procedures and technologies are advancing, embolization is becoming an increasingly common method for minimally invasive interventions. From treating internal bleeding to targeting abnormal… Aug 30 Biomedica

  4. Un tejado verde en Gante

    La ciudad de Gante está fuertemente comprometida con el medio ambiente y desarrolla numerosas acciones en este ámbito, como la implantación de una zona de bajas emisiones sin vehículos altamente contaminantes. Con este mismo afán, la planta de Rousselot Gante se compromete a limitar el impacto de su

  5. [Translate to Spanish:] Download X-Pure whitepapers

    Whitepaper on Rousselot low endotoxin gelatins and collagens for biomedical applications. X-Pure Whitepaper: Low endotoxin gelatins and collagens for (bio)medical applications X-Pure Whitepaper: Gelatin for safe micro- and submicron Particle applications X-Pure Whitepaper: Low endotoxin gelatins in

  6. X-Pure GelMA | Research Grade Gelatin Methacryloyl | Rousselot Biomedical

    ‎Read our free infographic and find out more about customization and co-development now. X-Pure GelMA What is X-Pure GelMA? X-Pure ® GelMA is the world’s first gelatin methacryloyl (GelMA or GelMOD) produced under GMP conditions 1 , making it suitable for clinical applications in advanced biomedical

  7. Los cirujanos necesitan mejores agentes hemostáticos

    Hemostatics Every year, 5 million people die from blood loss, primarily during surgery. Surgeons require better hemostatic agents to reduce the number of deaths from hemorrhaging. [1] Gelatin is the hemostatic of choice Gelatin can absorb up to 40 times its weight in blood or fluids and can expand u

  8. Valoramos la importancia de la calidad y la seguridad

    For medical devices that require ultra-low endotoxin levels with LPS <10 EU/g, such as those involving cell culture, find out more about X-Pure®. Find out more about Quali-Pure ® - our new range of high-quality gelatins that offer medical manufacturers endotoxin-controlled gelatin. Calidad Como soci